Analysts Offer Insights on Financial Companies: Charles Schwab (SCHW) and GoHealth (GOCO)

Analysts have been eager to weigh in on the Financial sector with new ratings on Charles Schwab (SCHWResearch Report) and GoHealth (GOCOResearch Report).

Charles Schwab (SCHW)

Raymond James analyst Patrick O’Shaughnessy maintained a Hold rating on Charles Schwab yesterday. The company’s shares closed last Friday at $56.41.

According to, O’Shaughnessy is a 5-star analyst with an average return of 9.3% and a 60.0% success rate. O’Shaughnessy covers the Financial sector, focusing on stocks such as AssetMark Financial Holdings, Intercontinental Exchange, and Focus Financial Partners.

Currently, the analyst consensus on Charles Schwab is a Moderate Buy with an average price target of $85.03, implying a 50.4% upside from current levels. In a report issued on March 13, Barclays also maintained a Hold rating on the stock with a $79.00 price target.

See the top stocks recommended by analysts >>

GoHealth (GOCO)

Bank of America Securities analyst Michael Cherny reiterated a Sell rating on GoHealth yesterday and set a price target of $11.00. The company’s shares closed last Friday at $13.22.

According to, Cherny is a 4-star analyst with an average return of 6.8% and a 52.7% success rate. Cherny covers the Healthcare sector, focusing on stocks such as Patterson Companies, AmerisourceBergen, and Pear Therapeutics.

The word on The Street in general, suggests a Moderate Sell analyst consensus rating for GoHealth with a $12.50 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on SCHW:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More